Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:11 November 2008
Dear Readers,
- The Association Between Pressure Ulcers and Endothelial Dysfunction in a Cohort of Community ElderlyIssue:11 November 2008
Abstract: Vascular disease is a known risk factor for pressure ulcer development, but the underlying mechanisms of this association are less established. The authors evaluated the relationship between endothelial function (EF) and history of pressure ulcers in a nested case-control study of community-dwelling elderly, 60 years and older. Endothelial function was measured using peripheral arterial tonometry, and persons with a history of pressure ulcers in the past 5 years (n = 7) were matched 2:1 by age and gender to controls with no history of pressure ulcers (n = 14).
- Issue:11 November 2008
Abstract: Evidence-based choices for treating burns in children are not well defined. Skin substitutes and contemporary dressings offer potential advantages over traditional treatment with topical antimicrobial agents in treating partial-thickness burns. Newer treatment modalities may reduce morbidity, financial burdens, and scarring by accelerating healing.
- Issue:11 November 2008
Abstract: The following case reports on the successful use of Integra® (Integra LifeSciences, Plainsboro, NJ) as an alternative for coverage of exposed tibia in a patient with necrotizing fasciitis and significant comorbidities. Necrotizing fasciitis is a generalized term that is used to describe soft tissue infections in which necrosis of the fascia and subcutaneous tissue occurs. Necrotizing fasciitis will often begin with disproportionate pain, localized erythema, and skin discoloration with vesicle formation.
- Issue:11 November 2008
Abstract: Purpose. Silver wound dressings are widely used in the treatment of burns. Dressings differ in material characteristics, various antimicrobial activities, and ease of use. The purpose of this study was to evaluate both dressing performance and amount of pain during the dressing changes of 2 silver dressings Urgotul SSD® (Laboratoires Urgo, Chenove, France), and Contreet Ag® (Coloplast, Minneapolis, MN) in children. Methods. A retrospective cohort study was performed with 2 groups of 20 burns treated with Urgotul SSD and Contreet Ag until the wounds were healed or grafted.
- Issue:11 November 2008
Abstract: Aim. To identify the impact of pain on quality of life (QOL) of patients with chronic venous ulcers. Methods. A cross-sectional study was performed on 40 outpatients with chronic venous ulcers who were recruited at one outpatient care center in São Paulo, Brazil. WHOQOL-Bref was used to assess QOL, the McGill Pain Questionnaire-Short Form (MPQ) to identify pain characteristics, and an 11-point numerical pain rating scale to measure pain intensity. Kruskall-Wallis or ANOVA test, with post-hoc correction (Tukey test) was applied to compare groups.
- Issue:11 November 2008
Arobella Medical CEO issued US Patent for Ultrasound Technology
Arobella Medical LLC (Minneapolis, Minn) announced that its Co-founder, President and CEO Eliaz Babaev, PhD, was issued a US patent that covers technology employed in the next generation of the company’s Qoustic Wound Therapy System®.
- Issue:11 November 2008
Talley Group Announces New Addition to the Venturi™ System Portfolio
Talley Group (Romsey Hampshire, United Kingdom) will feature their next generation negative pressure wound therapy system, the Venturi™ Compact, at forthcoming exhibits. Talley Group executives have been listening to and consulting with clinicians to precisely design this smaller unit that is packed with the same functionality as the existing Venturi system with additional features and benefits.
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
